Tradestie Institutional Equity Comparison Engine
GAB vs GRX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GRX Overall Edge
GRX Captures Institutional Edge (1โ0 Pillars ยท 2โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to The Gabelli Healthcare & Wellness Trust (GRX) driven by superior Momentum & Technical. Fundamentally, GAB trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus GRX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, GAB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
GAB N/M vs GRX N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
GRX
1Y -12.3% vs +11.5% ยท 52W Pos 14% vs 91%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
GAB
NYSE
The Gabelli Equity Trust Inc.
Institutional Equity
$5.27
-1.86% 1D
Market Cap
$1.9B
1M Return
+2.33%
1Y Return
-12.31%
Forward P/E
N/M
Unified AI Score
45.7 / 100
HOLD
Tech 48.0
Fund 45.0
Flow 50.0
Mom 50.0
GRX
NYSE
The Gabelli Healthcare & Wellness Trust
Institutional Equity
$10.58
+1.63% 1D
Market Cap
$142.9M
1M Return
+4.86%
1Y Return
+11.49%
Forward P/E
N/M
Unified AI Score
41.3 / 100
SELL
Tech 30.0
Fund 43.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
GAB -12.31%
GRX +11.49%
Spread: +23.8 pp (GRX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
GAB TTM Op. Margin: N/A
GRX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GAB vs GRX. Trailing 12-month operating profitability (GAB N/A vs GRX N/A) and valuation multiples (GAB N/M vs GRX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GAB | GRX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.9B | $142.9M | Larger Scale | GAB |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 14% ($5โ$6) | 91% ($9โ$11) | Stronger Trend | GRX |
| Beta / 30D Volatility Risk Regime | 0.67ฮฒ ยท 19% Vol | 0.14ฮฒ ยท 14% Vol | Lower Realized Risk | GRX |
| Unified Institutional Score Composite Signal | 45.7 / 100 (HOLD) | 41.3 / 100 (SELL) | Higher Composite | GAB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full GAB vs GRX Buy Guide
GAB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
GRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither GAB nor GRX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.